4G9R | B-Raf V600E Kinase Domain Bound to a Type II Dihydroquinazoline Inhibitor | date | 2012-07-24 |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
authors | Voegtli, W.C., Sturgis, H.L. | ||||||||||||||
compound | source | ||||||||||||||
symmetry |
| ||||||||||||||
crystal cell |
| ||||||||||||||
method | X-Ray Diffraction | resolution | 3.20 | ||||||||||||
ligand | B1E | enzyme |
| ||||||||||||
Gene Ontology |
| ||||||||||||||
Primary reference | Pyrazolopyridine inhibitors of B-Raf(V600E). Part 4: rational design and kinase selectivity profile of cell potent type II inhibitors., Wenglowsky S, Moreno D, Laird ER, Gloor SL, Ren L, Risom T, Rudolph J, Sturgis HL, Voegtli WC, Bioorg Med Chem Lett. 2012 Oct 1;22(19):6237-41. doi: 10.1016/j.bmcl.2012.08.007., Epub 2012 Aug 10. PMID:22954737 |
Data retrieval |
View 4G9R in 3D |
Visual 3D analysis of 4G9R |
Structure-derived information |
Sequence-derived information |
Other resources with information on 4G9R |
Movements, Movies and Images |
OCA© by Jaime Prilusky, 1996-2014,2022 Bioinformatics Unit Weizmann Institute of Science |